Collaboration of Statisticians: A perspective
*Rajeshwari Sridhara, FDA Keywords: clinical trial designs, composite outcomes, FDA Statisticians, collaboration New drug development is becoming more and more complex with new classification of diseases, use of complex clinical trial designs, composite outcomes, concomitant medications and multi-national studies, just to name a few. Statisticians at FDA, Academia and Industry play an important role and contribute significantly in this complex process. This presentation will include the role of Statisticians at FDA and outline possible areas where Statisticians from different sectors can collaborate to solve complex issues.
|
Key Dates
-
April 30 - May 22, 2013
Invited Abstract Submission Open -
June 4, 2013
Online Registration Opens -
August 9 - August 23, 2013
Invited Abstract Editing -
August 23, 2013
Short Course materials due from Instructors -
August 26, 2013
Housing Deadline -
September 9, 2013
Cancellation Deadline and Registration Closes @ 11:59 pm EDT -
September 16 - September 18, 2013
Marriott Wardman Park, Washington, DC